Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;47(10):721-722.
doi: 10.1177/03913988241269508. Epub 2024 Sep 2.

How I treat rhabdomyolysis-induced AKI? A different perspective

Gabriella Bottari  1 , Isabella Guzzo  2
Affiliations

How I treat rhabdomyolysis-induced AKI? A different perspective

Gabriella Bottari et al. Int J Artif Organs. 2024 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Upper section of the figure shows time course of Creatinine Kinase (CK) during the extra-corporeal therapy with Continuous Kidney Replacement Therapy (CKRT) and Cytosorb hemoadsorption. The white window depicts the time course of CK measured at the inlet and the outlet of the cartridge between Time 0 (0 h) and after 6 h (6 h). At the different time points is reported the CK removal ratio of the cartridge (calculated as [Concentration at baseline (CB0) − Concentration at the end of the treatment (Cend)/CB0 × 100]). Bottom section of the figure shows the histograms ad different time points for creatinine blood level (yellow bars), urine output measured in ml in 24 h (orange bars), urine output measured as ml × kg/h (blue bars), ultrafiltration rate of CKRT (ml/h).
See this image and copyright information in PMC

References

    1. Scharf C, Liebchen U, Paal M, et al.. Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysis. Crit Care 2021; 25(1): 41. - PMC - PubMed
    1. Albrecht F, Schunk S, Fuchs M, et al.. Rapid and effective elimination of myoglobin with cytosorb® hemoadsorber in patients with severe rhabdomyolysis. Blood Purif 2023; 2: 1–8. - PubMed
    1. Raju NA, Rao SV, Joel JC, et al.. Predictive value of serum myoglobin and creatine phosphokinase for development of acute kidney injury in traumatic rhabdomyolysis. Indian J Crit Care Med 2017; 21(12): 852–856. - PMC - PubMed
    1. Grafe C, Liebchen U, Greimel A, et al.. The effect of CytoSorb application on kidney recovery in critically ill patients with severe rhabdomyolysis. A propensity score matching analysis. Ren Fail 2023; 45(2): 2239231. - PMC - PubMed

LinkOut - more resources